Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.
Topline data from 400-person sentinel cohort of the Phase 2b COVID-19 trial anticipated early Q2 2026 Published positive clinical results in the first quarter of 2026 demonstrating oral norovirus ...
The COVID pandemic ushered mRNA vaccines into the spotlight, and the technology has even greater potential. Here’s what to ...
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...
HENRICO COUNTY, Va. — Infectious disease researchers in Henrico County are working on the final stages of the world’s first norovirus vaccine. Clinical Research Partners (CRP) is looking for people 60 ...